Results 261 to 270 of about 774,384 (405)

A case of rapidly progressive interstitial lung disease. [PDF]

Respir Med Case Rep
Quy K, Vo TM, Bui-Pham TH, Nguyen DN, Nguyen MH, Thi Dinh HH, Pham VL.   +6 more
europepmc   +1 more source

Linezolid prevents fibroblast activation and ameliorates tissue fibrosis by inhibition of mitochondrial translation

Arthritis &Rheumatology, Accepted Article.
Background Beyond its role as a ribosome‐targeting antibiotic, linezolid was recently shown to modulate immune responses by inhibiting mitochondrial translation. Since mitochondrial dysfunction is implicated in various fibrotic diseases, including systemic sclerosis (SSc), this study aimed to evaluate the antifibrotic potential of linezolid and ...
Xuezhi Hong, Yanhua Xiao, Haodong Qi, Shihao Zhu, Tim Filla, Andrea‐Hermina Györfi, Yi‐Nan Li, Meilin Xu, Langxian Zhi, Thuong Trinh‐Minh, Clara Dees, Georg Schett, Jörg H.W. Distler, Alexandru‐Emil Matei   +13 more
wiley   +1 more source

Association of serological markers and interstitial lung disease in patients with suspected myositis. [PDF]

Medicine (Baltimore)
Shi L, Wu Y, Fu J, Liu X, Wang P.
europepmc   +1 more source

A cooperative release of mitochondrial DNA from platelets and neutrophils drives an interferon signature in systemic sclerosis

Arthritis &Rheumatology, Accepted Article.
Objective Mitochondria are organelles with a hypomethylated circular genome. Mitochondrial DNA (mtDNA) in the systemic circulation has been implicated in inflammation. This study investigates the role of circulating DNA in systemic sclerosis (SSc) and the cellular mechanisms governing its release.
Stavros Giaglis, André N. Tiaden, Simone Häner‐Massimi, Diego Kyburz, Cedric André, Anton Glück, Enrico Ferrero, Stuart Hawtin, Tobias Junt, Ulrich A. Walker   +9 more
wiley   +1 more source

The benefits of a rapid diagnostic primary care circuit for interstitial lung disease. [PDF]

NPJ Prim Care Respir Med
Bermudo G, Rivera-Ortega P, Vicens-Zygmunt V, Del Rio B, Bolivar S, Serra E, Ferrer F, Llatjós R, Rivas F, López-Lisbona R, García L, Santos S, Luburich P, Molina-Molina M.   +13 more
europepmc   +1 more source

Utility of Transbronchial vs Surgical Lung Biopsy in the Diagnosis of Suspected Fibrotic Interstitial Lung Disease [PDF]

, 2016
Jamie Sheth, John A. Belperio, Michael C. Fishbein, Ella A. Kazerooni, Amir Lagstein, Susan Murray, Jeff L. Myers, Richard H. Simon, Thomas H. Sisson, Baskaran Sundaram, Eric S. White, Meng Xia, David A. Zisman, Kevin R. Flaherty   +13 more
openalex   +1 more source

Long‐Term Outcomes of Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation for Systemic Sclerosis Patients with Impaired Cardiac Function

Arthritis &Rheumatology, Accepted Article.
Objective High intensity conditioning autologous hematopoietic stem cell transplantation (AHSCT) is standard of care for patients with advanced SSc. The role of reduced intensity conditioning (RIC) prior to AHSCT in this population remains unclear. We conducted this study to determine the long‐term outcomes of RIC AHSCT in SSc patients with cardiac ...
Yonatan Lean, Carrie Richardson, Anthony Esposito, Katy Bedjeti, George E. Georges   +4 more
wiley   +1 more source

Clinician opinions on starting treatment for opportunistic infection prevention in interstitial lung disease: the STOP-ILD study

ERJ Open Research
Jack Evans, Nicholas D. Weatherley, Stephen M. Bianchi   +2 more
doaj   +1 more source

Exploring Antifibrotic Strategies for Interstitial Lung Disease in Rheumatoid Arthritis: A Narrative Review. [PDF]

Open Access Rheumatol
Farizani Gohari NS, Hoseinzadeh F, Khalaji A, Mirzaei S, Gholinataj Jelodar M.   +4 more
europepmc   +1 more source

Comparative analysis of the characteristics and trends of adverse drug reaction reports from patients in Japan and the Japanese Adverse Drug Event Report database

British Journal of Clinical Pharmacology, EarlyView.
Aims Spontaneous reporting of adverse drug reactions (ADR) after a product has reached the market is essential for drug safety. This study analysed patient ADR reports and compared them with reports from the Japanese Adverse Drug Event Report (JADER) database to identify differences and trends.
Masami Tsuchiya, Ryohkan Funakoshi, Koichi Masuyama, Nariyasu Mano, Satoko Hori, Taku Obara   +5 more
wiley   +1 more source